The U.S. Food and Drug Administration on Friday approved a new blood test for the early detection of Alzheimer's disease in ...

Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, ...

But the FDA and the Centers for Disease Control and Prevention (CDC) released a safety notice on May 9 recommending that adults over 60 years old pause use of the vaccine due to fatal complications.

The CDC recommends the vaccine pause while it investigates “serious adverse events,” including neurologic and cardiac events.

US health officials are telling travelers aged 60 and older to avoid a chikungunya vaccine while they investigate possible side effects.

The Department of Agriculture has temporarily halted the import of live cattle, horses and bison from Mexico to stop the ...

Researchers say they've discovered an already approved migraine drug that can stop symptoms hours before a severe headache ...

The FDA and CDC recommended a pause in administering Ixchiq, a chikungunya vaccine, in adults ages 60 and above after 17 serious adverse events, including two deaths.  About 80,000 Ixchiq doses have ...

The Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) are recommending a pause in the use of the chikungunya vaccine, called Ixchiq, for adults age 60 and ...

Centres for Disease Control and Prevention (CDC) has issued an advisory urging American travellers over the age of 60 years ...

The United States is advising travellers aged 60 and up to hold off on getting the chikungunya vaccine while it looks into ...